These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25182635)
1. A population pharmacokinetic modeling approach shows that serum penicillin G concentrations are below inhibitory concentrations by two weeks after benzathine penicillin G injection in the majority of young adults. Neely M; Kaplan EL; Blumer JL; Faix DJ; Broderick MP Antimicrob Agents Chemother; 2014 Nov; 58(11):6735-41. PubMed ID: 25182635 [TBL] [Abstract][Full Text] [Related]
2. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease. Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748 [TBL] [Abstract][Full Text] [Related]
3. Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever. Page-Sharp M; Coward J; Moore BR; Salman S; Marshall L; Davis TME; Batty KT; Manning L Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559267 [TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia. Kado J; Salman S; Hand R; O'Brien M; Ralph A; Bowen AC; Page-Sharp M; Batty KT; Dolman V; Francis JR; Carapetis J; Manning L J Antimicrob Chemother; 2022 Sep; 77(10):2679-2682. PubMed ID: 35822635 [TBL] [Abstract][Full Text] [Related]
5. A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies. Hand RM; Salman S; Newall N; Vine J; Page-Sharp M; Bowen AC; Gray K; Baker A; Kado J; Joseph J; Marsh J; Ramsay J; Sika-Paotonu D; Batty KT; Manning L; Carapetis J J Antimicrob Chemother; 2019 Jul; 74(7):1984-1991. PubMed ID: 30989171 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study. Kado J; Salman S; Hla TK; Enkel S; Henderson R; Hand RM; Hort A; Page-Sharp M; Batty K; Moore BR; Bennett J; Anderson A; Carapetis J; Manning L Antimicrob Agents Chemother; 2023 Dec; 67(12):e0096223. PubMed ID: 37971244 [TBL] [Abstract][Full Text] [Related]
7. Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children with rheumatic fever and controls. Lamas MC; Hilário MO; Francisco W; Goldenberg J; Naspitz CK J Investig Allergol Clin Immunol; 1992; 2(5):268-73. PubMed ID: 1342909 [TBL] [Abstract][Full Text] [Related]
8. Factors associated with loss of penicillin G concentrations in serum after intramuscular benzathine penicillin G injection: a meta-analysis. Broderick MP; Hansen CJ; Faix DJ Pediatr Infect Dis J; 2012 Jul; 31(7):722-5. PubMed ID: 22481428 [TBL] [Abstract][Full Text] [Related]
9. Rheumatic fever prophylaxis using benzathine penicillin G (BPG): two- week versus four-week regimens: comparison of two brands of BPG. Kassem AS; Zaher SR; Abou Shleib H; el-Kholy AG; Madkour AA; Kaplan EL Pediatrics; 1996 Jun; 97(6 Pt 2):992-5. PubMed ID: 8637789 [TBL] [Abstract][Full Text] [Related]
10. Rheumatic fever prophylaxis in South Africa--is bicillin 1,2 million units every 4 weeks appropriate? Daniels ED; Mohanlal D; Pettifor JM S Afr Med J; 1994 Aug; 84(8 Pt 1):477-81. PubMed ID: 7825080 [TBL] [Abstract][Full Text] [Related]
11. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Ganesan A; Mesner O; Okulicz JF; O'Bryan T; Deiss RG; Lalani T; Whitman TJ; Weintrob AC; Macalino G; Agan BK; Clin Infect Dis; 2015 Feb; 60(4):653-60. PubMed ID: 25389249 [TBL] [Abstract][Full Text] [Related]
12. Treatment of late syphilis with 2.4 million units benzathine penicillin G (BPG): tolerance of single versus divided doses. Janier M; Libar E; Bonnet A; Meunier P; Tabet M; Mathourais M; Paterour C; Porcher R Sex Transm Dis; 2012 May; 39(5):359-60. PubMed ID: 22504599 [TBL] [Abstract][Full Text] [Related]
13. Serum penicillin G levels are lower than expected in adults within two weeks of administration of 1.2 million units. Broderick MP; Hansen CJ; Russell KL; Kaplan EL; Blumer JL; Faix DJ PLoS One; 2011; 6(10):e25308. PubMed ID: 21991307 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Safety of Intramuscular Injectable Benzathine Penicillin G in Japanese Healthy Participants. Li Y; Okayama A; Hagi T; Muto C; Raber S; Nagashima M J Clin Pharmacol; 2024 Oct; 64(10):1259-1266. PubMed ID: 38736032 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of rheumatic fever prophylaxis regimens. Thamlikitkul V; Kobwanthanakun S; Pruksachatvuthi S; Lertluknithi R J Int Med Res; 1992 Feb; 20(1):20-6. PubMed ID: 1568517 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection: a randomized, crossover, population pharmacokinetic study in healthy adult volunteers. Kado JH; Salman S; Henderson R; Hand R; Wyber R; Page-Sharp M; Batty K; Carapetis J; Manning L J Antimicrob Chemother; 2020 Oct; 75(10):2951-2959. PubMed ID: 32696033 [TBL] [Abstract][Full Text] [Related]
17. Penicillin concentrations after increased doses of benzathine penicillin G for prevention of secondary rheumatic fever. Currie BJ; Burt T; Kaplan EL Antimicrob Agents Chemother; 1994 May; 38(5):1203-4. PubMed ID: 8067767 [TBL] [Abstract][Full Text] [Related]
18. Apparent failure of one injection of benzathine penicillin G for syphilis during pregnancy in human immunodeficiency virus-seronegative African women. Donders GG; Desmyter J; Hooft P; Dewet GH Sex Transm Dis; 1997 Feb; 24(2):94-101. PubMed ID: 9111755 [TBL] [Abstract][Full Text] [Related]
19. Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children. Ginsburg CM; McCracken GH; Zweighaft TC Pediatrics; 1982 Apr; 69(4):452-4. PubMed ID: 7041073 [TBL] [Abstract][Full Text] [Related]
20. A Multicenter Study Evaluating Ceftriaxone and Benzathine Penicillin G as Treatment Agents for Early Syphilis in Jiangsu, China. Cao Y; Su X; Wang Q; Xue H; Zhu X; Zhang C; Jiang J; Qi S; Gong X; Zhu X; Pan M; Ren H; Hu W; Wei Z; Tian M; Liu W Clin Infect Dis; 2017 Oct; 65(10):1683-1688. PubMed ID: 29020150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]